Label: EUCERIN DAILY PROTECTION FACE- ensulizole, octinoxate, octisalate, titanium dioxide, zinc oxide lotion
- NDC Code(s): 10356-323-04, 10356-323-11, 10356-323-25, 10356-323-27
- Packager: Beiersdorf Inc
- Category: HUMAN OTC DRUG LABEL
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 30, 2022
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- INDICATIONS & USAGE
- WARNINGS
- DO NOT USE
- WHEN USING
- STOP USE
- KEEP OUT OF REACH OF CHILDREN
-
DOSAGE & ADMINISTRATION
Directions
For sunscreen use: • apply liberally 15
minutes before sun exposure • use a water
resistant sunscreen if swimming or sweating
• reapply at least every 2 hours
• Sun Protection Measures. Spending time in
the sun increases your risk of skin cancer and
early skin aging. To decrease this risk regularly
use a sunscreen with a Broad Spectrum SPF
value of 15 or higher and other sun protection
measures including:
• limit time in the sun, especially from
10 a.m.-2 p.m.• wear long-sleeved shirts,
pants, hats, and sunglasses.
• Children under 6 months of age: Ask a doctor -
INACTIVE INGREDIENT
Inactive Ingredients
Water, Glycerin, C12-15 Alkyl Benzoate,
Dimethicone, Cyclomethicone, Methylpropanediol,
Cetearyl Alcohol, Cetyl Alcohol, Ceteareth-20,
Phenoxyethanol, Glyceryl Stearate SE, Sodium
Lactate, Lactic Acid, 1,2-Hexanediol,
Hydrogenated Coco-Glycerides,
VP/Hexadecene Copolymer, Xanthan Gum,
PEG-40 Castor Oil, Sodium Hydroxide,
Trisodium EDTA, Alumina, Sodium Cetearyl
Sulfate, Triethoxycaprylylsilane, Simethicone
- QUESTIONS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
EUCERIN DAILY PROTECTION FACE
ensulizole, octinoxate, octisalate, titanium dioxide, zinc oxide lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:10356-323 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ENSULIZOLE (UNII: 9YQ9DI1W42) (ENSULIZOLE - UNII:9YQ9DI1W42) ENSULIZOLE 2 g in 100 mL OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 7.5 g in 100 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 4.5 g in 100 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 2.4 g in 100 mL ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 4.8 g in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) GLYCERIN (UNII: PDC6A3C0OX) ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ) DIMETHICONE (UNII: 92RU3N3Y1O) CYCLOMETHICONE (UNII: NMQ347994Z) CETYL ALCOHOL (UNII: 936JST6JCN) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) SODIUM LACTATE (UNII: TU7HW0W0QT) LACTIC ACID (UNII: 33X04XA5AT) COCO-GLYCERIDES (UNII: ISE9I7DNUG) POLYOXYL 40 CASTOR OIL (UNII: 4ERD2076EF) SODIUM CETOSTEARYL SULFATE (UNII: 7ZBS06BH4B) XANTHAN GUM (UNII: TTV12P4NEE) EDETATE TRISODIUM (UNII: 420IP921MB) SODIUM HYDROXIDE (UNII: 55X04QC32I) ALUMINUM OXIDE (UNII: LMI26O6933) PHENOXYETHANOL (UNII: HIE492ZZ3T) METHYLPROPANEDIOL (UNII: N8F53B3R4R) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) VINYLPYRROLIDONE/HEXADECENE COPOLYMER (UNII: KFR5QEN0N9) TRIMETHOXYCAPRYLYLSILANE (UNII: FZ07E4LW2M) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:10356-323-04 30 mL in 1 TUBE; Type 0: Not a Combination Product 08/12/2015 2 NDC:10356-323-25 5 mL in 1 TUBE; Type 0: Not a Combination Product 08/12/2015 3 NDC:10356-323-27 4 mL in 1 PACKET; Type 0: Not a Combination Product 08/12/2019 4 NDC:10356-323-11 118 mL in 1 BOTTLE; Type 0: Not a Combination Product 08/12/2015 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part352 08/12/2015 Labeler - Beiersdorf Inc (001177906)